French market for ICDs (implantable cardioverter defibrillators) set to soar
This article was originally published in Clinica
Executive Summary
Implantable cardioverter defibrillators (ICDs) should at last be appearing soon on the list of products used in French private sector hospitals that are reimbursed. After years of campaigning by industry, the national reimbursement pricing committee for medical devices sold in private hospitals has submitted its backing for reimbursement to the health ministry and a decision is expected imminently, along with the list of private clinics where these products may be implanted.